XML 14 R3.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Statement of Comprehensive Income [Abstract]        
Product revenue, net $ 96,131 $ 86,327 $ 267,156 $ 268,139
Operating expenses:        
Cost of sales 1,275 1,216 3,927 4,328
Research and development 28,091 33,869 85,345 86,489
Selling, general and administrative 30,533 26,523 90,071 79,630
Total operating expenses 59,899 61,608 179,343 170,447
Income from operations 36,232 24,719 87,813 97,692
Interest and other income 72 622 457 3,103
Income before income taxes 36,304 25,341 88,270 100,795
Income tax expense (5,833) (3,716) (7,811) (20,778)
Net income 30,471 21,625 80,459 80,017
Other comprehensive income:        
Net unrealized gain (loss) on available-for-sale investments, net of tax effect of $8, $109, $85 and $(81), respectively (23) (347) (265) 259
Foreign currency translation gain (loss), net of tax (77) 84 (35) 57
Total comprehensive income $ 30,371 $ 21,362 $ 80,159 $ 80,333
Basic net income per share (in dollars per share) $ 0.26 $ 0.19 $ 0.69 $ 0.70
Diluted net income per share (in dollars per share) $ 0.24 $ 0.17 $ 0.63 $ 0.65
Weighted-average shares outstanding used in computing net income per share        
Basic (in shares) 115,791 115,734 116,297 115,107
Diluted (in shares) 125,136 124,464 127,173 123,337